RPG LifeScience. Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'07
No of Months
12
Profit Before Tax
9.94
Adjustment
15.00
Changes In working Capital
-9.38
Cash Flow after changes in Working Capital
15.56
Cash Flow from Operating Activities
15.32
Cash Flow from Investing Activities
-6.21
Cash Flow from Financing Activities
-28.21
Net Cash Inflow / Outflow
-19.10
Opening Cash & Cash Equivalents
27.10
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
Effect of Foreign Exchange Fluctuations
0.00
Closing Cash & Cash Equivalent
8.00
Compare Cash Flow Results of RPG LifeScience.
Figures in Rs cr
consolidated Cash Flow Results
Change(INR)
Change(%)
Profit Before Tax
99408
2399.36
97,009.00
4043.10%
Adjustment
149994
212.2
1,49,782.00
70585.20%
Changes In working Capital
-93845
20.42
-93,865.00
-459673.95%
Cash Flow after changes in Working Capital
155557
2631.98
1,52,926.00
5810.27%
Cash Flow from Operating Activities
153192
2152.45
1,51,040.00
7017.10%
Cash Flow from Investing Activities
-62108
-2080.52
-60,028.00
-2885.22%
Cash Flow from Financing Activities
-282078
5.27
-2,82,083.00
-5352623.72%
Net Cash Inflow / Outflow
-190994
77.19
-1,91,071.00
-247533.61%
Opening Cash & Cash Equivalents
271005
304.82
2,70,701.00
88806.57%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
80011
382.01
79,629.00
20844.74%
Cash Flow - Snapshot (Standalone) - Mar'24
YoY Growth in year ended Mar 2024 is 3.90% vs 40.26% in Mar 2023
Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
94.36
90.82
3.90%